Vlad Radulescu

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Octapharma
    Topic:
    hemophilia advisory board
    Date added:
    03/05/2026
    Date updated:
    03/05/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    sickle cell disease advisory board
    Date added:
    03/05/2026
    Date updated:
    03/05/2026
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sobi
    Topic:
    ITP advisory board
    Date added:
    03/05/2026
    Date updated:
    03/05/2026
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Topic:
    Hemophilia advisory board
    Date added:
    03/05/2026
    Date updated:
    03/05/2026
    Relationship end date:
    12/31/2025
Return to 8th Annual UK Healthcare Markey Cancer Center Review of Hematology and Immunotherapy